Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4, Open-Label Study Evaluating the Hemodynamic Effect of Differing Loading Regimens of Precedex in a Post-Surgical Intensive Care Patient Population

NCT01169571 is registered in ClinicalTrials.gov with Hospira, now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT01169571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01169571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4, Open-Label Study Evaluating the Hemodynamic Effect of Differing Loading Regimens of Precedex in a Post-Surgical Intensive Care Patient Population
Lead sponsor
Hospira, now a wholly owned subsidiary of Pfizer
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2011
Enrollment
373 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care unit